Correlation Between Raphael Pharmaceutical and XCPCNL Business

Can any of the company-specific risk be diversified away by investing in both Raphael Pharmaceutical and XCPCNL Business at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Raphael Pharmaceutical and XCPCNL Business into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Raphael Pharmaceutical and XCPCNL Business Services, you can compare the effects of market volatilities on Raphael Pharmaceutical and XCPCNL Business and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Raphael Pharmaceutical with a short position of XCPCNL Business. Check out your portfolio center. Please also check ongoing floating volatility patterns of Raphael Pharmaceutical and XCPCNL Business.

Diversification Opportunities for Raphael Pharmaceutical and XCPCNL Business

0.0

Correlation Coefficient

Raphael Pharmaceutical  XCPCNL Business

Pay attention - limited upside

The 3 months correlation between Raphael and XCPCNL is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Raphael Pharmaceutical and XCPCNL Business Services in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XCPCNL Business Services and Raphael Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Raphael Pharmaceutical are associated (or correlated) with XCPCNL Business. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XCPCNL Business Services has no effect on the direction of Raphael Pharmaceutical i.e., Raphael Pharmaceutical and XCPCNL Business go up and down completely randomly.

Pair Corralation between Raphael Pharmaceutical and XCPCNL Business

Given the investment horizon of 90 days Raphael Pharmaceutical is expected to generate 47.0 times less return on investment than XCPCNL Business. But when comparing it to its historical volatility, Raphael Pharmaceutical is 9.53 times less risky than XCPCNL Business. It trades about 0.02 of its potential returns per unit of risk. XCPCNL Business Services is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  0.08  in XCPCNL Business Services on October 9, 2024 and sell it today you would lose (0.07) from holding XCPCNL Business Services or give up 87.5% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	99.6%
Values	Daily Returns

Raphael Pharmaceutical  vs.  XCPCNL Business Services

Raphael Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Raphael Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

XCPCNL Business Services

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days XCPCNL Business Services has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, XCPCNL Business is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Raphael Pharmaceutical and XCPCNL Business

The main advantage of trading using opposite Raphael Pharmaceutical and XCPCNL Business positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Raphael Pharmaceutical position performs unexpectedly, XCPCNL Business can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XCPCNL Business will offset losses from the drop in XCPCNL Business' long position.

The idea behind Raphael Pharmaceutical and XCPCNL Business Services pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.